Primary Category:
Treatment Protocols
Disease Category:
Adjuvant Breast, Breast
Status:
Closed
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Eligible for screening study DCP 001
BR003 is closed to accrual effective April 22, 2022, at 5pm ET.
NCT#02488967
